ArticleBrain and behavior2026
Reviving Hope: Overcoming Deep Brain Stimulation Failure With Partial Cranial Nerve Radiofrequency Ablation in Primary Meige Syndrome.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peripheral facial palsy: contemporary advances and unresolved debates in management from pathogenic mechanisms to tailored reconstruction.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionDeep brain stimulation (DBS) is a standard treatment for refractory primary Meige syndrome (PMS), yet 30%-50% of patients experience suboptimal outcomes. Management strategies for these "DBS failures" remain undefined. This study evaluates the efficacy of partial cranial nerve radiofrequency ablation (RFA) as a salvage therapy for this challenging population.
methodsWe report a retrospective series of three PMS patients classified as "DBS non-responders" based on clinical refractory status or ineligibility for lead revision. Patients underwent imaging-guided partial RFA of the facial nerve (for blepharospasm) and/or mandibular nerve (for oromandibular dystonia). The procedure utilized a graded thermal protocol, titrated strictly to a mild, controlled functional impairment clinical endpoints.
resultsImmediate symptom remission was achieved in all cases. The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) Movement subscores decreased significantly (e.g., from 9 to 0 in Case 1, and 14 to 0.5 in Case 2). Procedural sequelae, including mild facial paralysis and masticatory weakness, were transient and resolved within 3-6 months. One patient experienced symptom recurrence at 14 months, which was successfully managed via repeat RFA.
conclusionPartial cranial nerve RFA is a feasible, effective, and repeatable salvage therapy for PMS following DBS failure. By targeting the peripheral conduction pathway, it offers a distinct mechanism of action and a practical alternative when central neuromodulation proves insufficient. Future studies with larger cohorts are warranted to validate these preliminary findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.